BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38332747)

  • 21. Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein-Barr virus in adult and pediatric Systemic lupus erythematosus patients.
    Das P; Minz RW; Saikia B; Sharma A; Anand S; Singh H; Singh S
    Lupus; 2022 Aug; 31(9):1054-1066. PubMed ID: 35607991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between HLA alleles and Epstein-Barr virus Zta-IgA serological status in healthy males from southern China.
    Yuan LL; Deng CM; Xue WQ; He YQ; Wang TM; Zhang JB; Yang DW; Zhou T; Wu ZY; Liao Y; Zheng MQ; Li DH; Cao LJ; Jia YJ; Zhang WL; Xiao RW; Luo LT; Tong XT; Wu YX; Huang JW; Jia WH
    J Gene Med; 2021 Nov; 23(11):e3375. PubMed ID: 34164868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune control of human γ-herpes infections.
    Münz C
    Semin Arthritis Rheum; 2024 Feb; 64S():152320. PubMed ID: 38007361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA alleles modulate EBV viral load in multiple sclerosis.
    Agostini S; Mancuso R; Guerini FR; D'Alfonso S; Agliardi C; Hernis A; Zanzottera M; Barizzone N; Leone MA; Caputo D; Rovaris M; Clerici M
    J Transl Med; 2018 Mar; 16(1):80. PubMed ID: 29587799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.
    Langer-Gould A; Wu J; Lucas R; Smith J; Gonzales E; Amezcua L; Haraszti S; Chen LH; Quach H; James JA; Barcellos LF; Xiang AH
    Neurology; 2017 Sep; 89(13):1330-1337. PubMed ID: 28855411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low sun exposure acts synergistically with high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels in multiple sclerosis etiology.
    Hedström AK; Huang J; Brenner N; Butt J; Kockum I; Waterboer T; Olsson T; Alfredsson L
    Eur J Neurol; 2021 Dec; 28(12):4146-4152. PubMed ID: 34435414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study.
    Dreyer-Alster S; Achiron A; Giovannoni G; Jacobs BM; Dobson R
    Sci Rep; 2022 Dec; 12(1):22158. PubMed ID: 36550182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis.
    Masuoka S; Kusunoki N; Takamatsu R; Takahashi H; Tsuchiya K; Kawai S; Nanki T
    PLoS One; 2018; 13(12):e0208957. PubMed ID: 30533036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.
    Hedström AK; Brenner N; Butt J; Hillert J; Waterboer T; Olsson T; Alfredsson L
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33465039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.
    Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
    Front Immunol; 2019; 10():2715. PubMed ID: 32038605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis.
    Olsson T
    Eur J Immunol; 2021 Jan; 51(1):56-59. PubMed ID: 33350470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
    Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
    Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis.
    Horton MK; Shim JE; Wallace A; Graves JS; Aaen G; Greenberg B; Mar S; Wheeler Y; Weinstock-Guttman B; Waldman A; Schreiner T; Rodriguez M; Tillema JM; Chitnis T; Krupp L; Casper TC; Rensel M; Hart J; Quach HL; Quach DL; Schaefer C; Waubant E; Barcellos LF
    Mult Scler; 2023 Apr; 29(4-5):505-511. PubMed ID: 36755464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J; Tengvall K; Bomfim Lima I; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I
    Brain; 2024 Apr; ():. PubMed ID: 38630618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB1 15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
    Anagnostouli M; Anagnostoulis G; Katsavos S; Panagiotou M; Kararizou E; Davaki P
    J Neurol Sci; 2014 Apr; 339(1-2):26-31. PubMed ID: 24576802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.